ScharpD.W.; LacyP.E.; SantiagoJ.V.Results of our first nine intraportal islet allografts into Type I (insulin-dependent) diabetic patients.Transplantation51: 76–85; 1991.
2.
WarnockG.L.; KnetemanN.M.; RyanE.A.Normoglycemia after transplantation of freshly isolated and cryopreserved pancreatic islets in Type I (insulin-dependent) diabetes mellitus.Diabetologia34: 55–58; 1991.
3.
RicordiL.; LacyP.E.; FinkeE.M.; OlackB.J.; ScharpD.W.Automated method for isolation of human pancreatic islets.Diabetes37: 413–420; 1988.
4.
BallingerW.F.; LacyP.E.Transplantation of intact pancreatic islets in rats.Surgery72: 175–186; 1972.
5.
DowningR.; MorrisseyS.; KiskeD.; ScharpD.W.Does the purity of intraportal islet isografts affect their endocrine function? J.Surg. Res.41: 41–46; 1986.
6.
PayneW.D.; SutherlandD.E.R.; MatasA.J.; GoreckiP.; NajarianJ.S.DL-ethiorine treatment of adult pancreatic donors: Amelioration of diabetes in multiple recipients with tissue from a single donor.Ann. Surg.189: 248–256; 1979.
7.
GrayD.W.R.; SuttonR.; McShaneP.; PetersM.; MorrisP.J.Exocrine contamination impairs implantation of pancreatic islets transplanted beneath the kidney capsule.J. Surg. Res.45: 432–442; 1988.
8.
MirkovitchV.; CampicheM.Intrasplenic autotransplantation of canine pancreatic tissues. Maintenance of normoglycemia after total pancreatectomy.Eur. Surg. Res.9: 173–190; 1977.
9.
KretschmerG.J.; SutherlandD.E.R.; MatasA.J.; CainT.L.; NajarianJ.S.The dispersed pancreas: transplantation without islet purification in totally pancreatectomized dogs.Diabetologia13: 495–502; 1977.
10.
FarneyA.C.; NajarianJ.S.; NakhlehR.E.Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis.Surgery110: 427–439; 1991.
11.
LaffertyK.J.; ProwseS.J.; SimeonovicC.J.; WarrenH.S.Immunobiology of tissue transplantation: A return to the passenger leukocyte concept.Ann. Rev. Immunol.1: 143–173; 1983.
12.
GoresP.F.; MayoralJ.; FieldM.J.Sutherland, D.E.R. Comparison of immunogenicity of purified and unpurified murine islet allografts.Transplantation41: 529–531; 1986.
StockP.G.; ArcherN.L.; ChenS.; FieldJ.; BachF.H.; SutherlandD.E.R.Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets.Transplantation52: 704–709; 1991.
15.
PipeleersD.G.; Pipeleers-MarichalM.; VanbrabandtB.; DuysS.Transplantation of purified islet cells in diabetic rats. II. Immunogenicity of allografted islet β-cells.Diabetes40: 920–930; 1991.
16.
KaufmanD.B.; PlattJ.L.; RabeF.L.; DunnD.L.; BachF.H.; SutherlandD.E.R.Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts.J. Exp. Med.172: 291–302; 1990.
GoresP.F.; NajarianJ.S.; StephanianE.; LloverasJ.J.; KelleyS.L.; SutherlandD.E.R.Insulin independence in Type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin.Lancet 341:8836: 19–21; 1993.
19.
RicordiC.; TzakisA.G.; CarrollP.B.Human islet isolation and allotransplantation in 22 consecutive cases.Transplantation53: 407–414; 1992.
